Australia's Inoviq eyes best day in 7 weeks on manufacturing deal

Inoviq

02/05/2022 03:42

** Shares of the medical diagnostics co  IIQ.AX  climb as
much as 7.14% to A$0.600, post their biggest intraday pct gain
since March 14  
    ** Co executes manufacturing deal with diagnostics product
supplier MP Biomedicals to help develop co's SubB2M-based tests
 urn:newsml:reuters.com:*:nASX67kGRv
    ** SubB2M technology detects pan-cancer biomarker 'Neu5Gc'
found in multiple forms of human cancer - IIQ 
    ** More than 254,000 shares change hands, compared with the
30-day average volume of 192,384 shares  
    ** Stock down 53.1% this year, as of last close, vs a 1.7%
decrease in the benchmark S&P/ASX 200 index  .AXJO 

 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))